-
Nirmatrelvir
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Nirmatrelvir 3C-Like Protease (3CLPRO) Inhibitor Thiab SARS-Cov-2 Mpro Inhibitor -
Ib 1038915-60-4
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Ib 1038915-60-4 Ovarian/Fallopian, tube/primary peritoneal cancer Tesaro Peb Hlis 8, 2028